Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C
<strong>Background:</strong> Blockade of tumour necrosis factor (anti-TNF) is effective in patients with Crohn’s Disease but has been associated with infection risk and neurological complications such as demyelination. Niemann-Pick disease Type C1 (NPC1) is a lysosomal storage disorder p...
Հիմնական հեղինակներ: | Williams, I, Pandey, S, Haller, W, Smith, D, Al Eisa, N, Platt, N, Platt, F, Uhlig, HH, Et al. |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
F1000Research
2022
|
Նմանատիպ նյութեր
-
Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C [version 1; peer review: 2 approved]
: David Smith, և այլն
Հրապարակվել է: (2022-01-01) -
Evaluation of new therapies in Niemann-Pick type C disease
: Al Eisa, N
Հրապարակվել է: (2014) -
Unbiased yeast screens identify cellular pathways affected in Niemann–Pick disease type C
: Colaco, A, և այլն
Հրապարակվել է: (2020) -
Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1.
: Smith, D, և այլն
Հրապարակվել է: (2009) -
Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease.
: Lloyd-Evans, E, և այլն
Հրապարակվել է: (2010)